A male patient with metachronous triple cancers of small cell lung, prostate and breast

被引:7
作者
Baba M. [1 ]
Higaki N. [1 ]
Ishida M. [1 ]
Kawasaki H. [1 ]
Kasugai T. [2 ]
Wada A. [2 ]
机构
[1] Department of Surgery, Kashiwara Municipal Hospital, Kashiwara 582-0005
[2] Department of Pathology, Osaka Medical Center for Cancer and Cardiovascular Diseases
关键词
Male breast cancer; Prostatic cancer; Small cell lung cancer;
D O I
10.1007/BF02967583
中图分类号
学科分类号
摘要
We present a very rare case of metachronous triple cancers, including small cell carcinoma of the lung, as well as prostate and male breast cancer. To our knowledge, this is the first documented case of its kind. A 64-year-old man was referred to our hospital with left nipple retraction. He had previously undergone lobectomy of the fight lung as treatment for small cell lung cancer at 57 years of age, and at 61 years of age, he had undergone prostatectomy and bilateral orchiectomy for prostate cancer, histologically determined to be moderately or poorly differentiated adenocarcinoma. Physical examination identified a painless irregular hard tumor in the left breast. Ultrasonography and magnetic resonance imaging (MRI) showed a nodular mass, and fine needle aspiration cytology of the mass revealed adenocarcinoma. Modified radical mastectomy was performed. Histological examination revealed that the breast tumor was scirrhous carcinoma, tl, no, mo, stage I. Immunohistochemistry demonstrated that the prostate tumor was positive for prostatic specific antigen (PSA) and negative for estrogen receptor (ER), while the breast tumor was positive for ER and negative for PS/k Primary breast cancer was diagnosed. At present, 1 year and 8 months after surgical removal of the breast cancer, the patient has had no recurrence of breast cancer, small cell lung cancer, or prostate cancer. We discuss the possible causes of the triple cancers in this case with reference to the literature.
引用
收藏
页码:170 / 174
页数:4
相关论文
共 37 条
  • [1] The Japan Lung Cancer Society: General Rule for Clinical and Pathological Record of Lung Cancer, pp. 26-32, (1999)
  • [2] Shida K., Fundamental and clinical study on anti-androgens-Androgen-dependency of prostatic tumors and clinical application of anti-androgens, Asian Med J, 24, pp. 747-777, (1981)
  • [3] The Japanese Breast Cancer Society: General Rules for Clinical and Pathological Recording of Breast Cancer, pp. 7-14, (1998)
  • [4] General Rule for Clinical and Pathological Studies on Prostatic Cancer, pp. 66-93, (1992)
  • [5] Boring C.C., Squires T., Tong T., Montgomery S., Cancer statistics, Ca-A Cancer Journal for Clinicians, 44, 1, pp. 7-26, (1994)
  • [6] Hiranuma T., Koyama S., Nakahara A., An autopsy case of synchronous primary cancer of the liver and male breast, Jpn J Gastroentero1, 84, pp. 1471-1475, (1987)
  • [7] Ohsawa T., Mouri Y., Suzuki Y., Sigmoid colon cancer heterochronously developed 5 years after operation for male breast cancer, JJpn Surg Assac, 55, pp. 679-682, (1994)
  • [8] Kojima A., Ikeuchi T., Inomata M., Y/6 chromosome translocation in a male with triple primary cancers involving the breast, J Cancer Res Clin Oncol, 117, pp. 479-483, (1991)
  • [9] Gardini G.F., Ginecomastia con degenerazione cancerigna in prostatico dopo trattamento estrogeno, Oncologia, 1, pp. 129-142, (1948)
  • [10] Abramson W., Warshawsky H., Cancer of the breast in the male, secondary to estrogenic administration: Report of a case, J Uro1, 59, pp. 76-82, (1948)